
Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The global cardiovascular stents market was valued at USD 14.06 Billion in 2024 driven by the rising prevalence of cardiovascular disease and advancements in stent technology across the globe. It is expected to grow at a CAGR of 4.80% during the forecast period 2025-2034 and attain a market value of USD 22.47 Billion by 2034.
Base Year
Historical Period
Forecast Period
In 2023, approximately 620 million people were living with heart and circulatory diseases. Thus, the rising prevalence of cardiovascular disease is the primary driver of the market.
The surge in new device approvals by regulatory bodies is a major market trend. For instance, in March 2024, Boston Scientific obtained FDA approval for the AGENT Drug-Coated Balloon, the first of its kind in the United States.
The ongoing research and development efforts to improve therapeutic options and the rising advancements in stent technology are likely to elevate the market value.
Value in USD Billion
2025-2034
Cardiovascular Stents Market Outlook
*this image is indicative*
Cardiovascular stents play a crucial role in the treatment of coronary artery disease by angioplasty, maintaining vessel patency, ensuring appropriate blood flow, and preventing restenosis. Current stents are equipped with advanced functions such as drug-releasing abilities and bioresorbable substances, which decrease long-term issues. Stents are used to address artery blockages resulting from atherosclerosis, a condition that can result in heart problems. Stents maintain the openness of arteries, promoting consistent blood circulation and reducing possible issues. The minimally invasive angioplasty procedure entails placing a catheter with a balloon and stent into the narrowed artery to expand the stent and compress the plaque.
Stents have revolutionized interventional cardiology by providing a less invasive choice with faster recovery times and improved patient results and thus contribute significantly to the growth of the cardiovascular stents market. Moreover, the introduction of drug-eluting stents, which are designed to release medication that helps prevent the narrowing of arteries, is likely to elevate the market value in the forecast period. Additionally, the rising improvements in stent technology, increasing healthcare expenditure in emerging economies, and the growing public awareness campaigns on heart disease are some of the factors poised to influence the market dynamics.
Rising Prevalence of Cardiovascular Diseases Spurs Market Growth
The rise in cardiovascular diseases (CVDs), due to lifestyle changes, urbanization, and aging populations impacts the global market for cardiovascular stents. In 2023, approximately 620 million people, out of the global population of 8 billion, were living with heart and circulatory diseases. Every year, around 60 million people worldwide develop these conditions, resulting in 1 in 13 individuals having a heart or circulatory disease. Thus, the rising burden of cardiovascular diseases such as coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other conditions, play a significant role in the growth of the market.
Advancements in Stent Technology Drive Increased Demand in the Cardiovascular Stents Market
Improvements in stent technology are driving expansion in the market. Advances in design, materials, and drug delivery systems have enhanced the safety and efficacy of stent procedures. For instance, in March 2024, Boston Scientific obtained FDA approval for the AGENT™ Drug-Coated Balloon, the first of its kind in the U.S. It offers a safe and effective alternative to address coronary in-stent restenosis and lower the risk of recurrence. Further, stents have become more resilient and compatible with the body. This is due to the use of high-strength alloys such as cobalt-chromium and biocompatible polymers.
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
“Cardiovascular Stents Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
Market Breakup by Type
Market Breakup by Material
Market Breakup by Disease Indication
Market Breakup by End User
Market Breakup by Region
Market Segmentation Based on the Type Holds a Significant Market Share
Different types of cardiovascular stents include drug-eluting stents (DES), bioresorbable stents, bare metal stents, dual therapy stents, and various other categories. Drug-eluting stents (DES) are the most frequently utilized because of their notable benefits in preventing restenosis in arteries. These stents release a drug that hinders cell growth and stops the formation of scar tissue, lowering the chance of the artery reoccluding. This technology has shown great success in the results over time, establishing drug-eluting stents as the top option in numerous situations. They are especially advantageous for patients at high risk of restenosis or those with intricate coronary lesions.
The Material Segment is Likely to Fuel Cardiovascular Stents Market Growth
Cardiovascular stents are classified based on the materials used, such as stainless steel, cobalt chromium, nitinol, and polymers. Cobalt chromium stents are preferred due to their strength and flexibility, allowing for thinner designs and improved deliverability. They provide excellent radial strength, decreasing the chance of deformation and supporting the overall health of arteries in the long run. Additionally, these stents are resistant to corrosion and have a smaller design for simpler maneuverability.
Based on region, the market report covers North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.
North America is expected to dominate the market powered by its state-of-the-art healthcare facilities, high rates of cardiovascular disease, and emphasis on medical progress. In the United States, heart disease is the top cause of death for most groups, with one person dying every 33 seconds with 702,880 deaths in 2022. Market growth is fostered by the presence of modern stent technologies such as drug-eluting and bioresorbable stents. Continual research and development, governmental support, and the rising preference for less intrusive techniques play a crucial role in the region's dominance in the cardiovascular stents market.
Europe is also poised to have a significant market share supported by the high prevalence of cardiovascular diseases, cutting-edge medical technologies, and favorable healthcare policies. Cardiovascular diseases are the main cause of disability and premature death in Europe, accounting for 42.5% of annual deaths, which is 10,000 per day. Nations such as Germany, France, and the United Kingdom experience a substantial burden of cardiovascular diseases, leading to an increased need for stent placement. The area adopts modern stent technologies such as drug-eluting and bioresorbable stents, backed by regulatory approvals and health authorities, which further aids the market expansion in the region.
The key features of the market report include patent analysis, funding, and investment analysis as well as strategic initiatives including recent partnerships and collaborations by the leading players. The major companies in the market are as follows:
Cordis is an American medical company developing and manufacturing devices for coronary and vascular diseases. In Oct 2022, Cordis announced the acquisition of MedAlliance, a Swiss company specializing in drug-eluting balloons. By acquiring MedAlliance, Cordis aims to serve two million patients worldwide by 2027 with their innovative SELUTION SLR drug-eluting balloon.
Abbott Laboratories is a US-based healthcare company that develops and sells medical products including pharmaceuticals, diagnostics, and nutritional items. In February 2023, Abbott acquired Cardiovascular Systems, Inc., a leader in atherectomy devices for treating artery disease. The deal is valued at USD 890 million, with CSI shareholders receiving USD 20 per share.
Boston Scientific Corporation, headquartered in Marlborough, Massachusetts, is a biomedical/biotechnology engineering firm and multinational manufacturer of medical devices. The company is known for its advanced stent products, which are widely used in the treatment of coronary artery disease.
Medtronic plc, an American-Irish medical device company, received FDA approval in May 2022 for the latest generation drug-eluting coronary stent system - the Onyx Frontier DES. This stent, part of the Resolute DES family, improves deliverability and acute performance in challenging cases, utilizing a best-in-class stent platform.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other players in the market are BIOTRONIK SE & Co KG, MicroPort Scientific Corporation, Cardinal Health Inc., Cook Medical Inc., C. R. Bard, Inc. (BD), Terumo Corporation, and B. Braun Melsungen AG.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
REPORT FEATURES | DETAILS |
Base Year | 2024 |
Historical Period | 2018-2024 |
Forecast Period | 2025-2034 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product Type |
|
Breakup by Type |
|
Breakup by Material |
|
Breakup by Disease Indication |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share